nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Discomfort—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Pamidronate—Discomfort—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Pamidronate—Angioedema—Dexamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Pamidronate—Angioedema—Betamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Angiopathy—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Confusional state—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Immune system disorder—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Malaise—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Malaise—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pamidronate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Oedema—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Syncope—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Syncope—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Infection—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Pamidronate—Infection—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Pamidronate—Shock—Triamcinolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Insomnia—Prednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Alopecia—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Shock—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Pamidronate—Paraesthesia—Prednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Pamidronate—Tachycardia—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Pamidronate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Pamidronate—Erythema—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Malnutrition—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Convulsion—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Convulsion—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Pamidronate—Hypertension—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Pamidronate—Hypertension—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Pamidronate—Myalgia—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Pamidronate—Myalgia—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Pamidronate—Anxiety—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Pamidronate—Anxiety—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Pamidronate—Discomfort—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Discomfort—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Hypotension—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Pain—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Oedema—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Oedema—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Insomnia—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Pamidronate—Insomnia—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Infection—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Infection—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Anaemia—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pamidronate—Shock—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Shock—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Agitation—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pamidronate—Tachycardia—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Pamidronate—Tachycardia—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Pamidronate—Angioedema—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Pamidronate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Pamidronate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Pamidronate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Pamidronate—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Pamidronate—Malaise—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Syncope—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Anorexia—Betamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Anorexia—Dexamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Fatigue—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Pamidronate—Fatigue—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Pamidronate—Pain—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Pamidronate—Hypotension—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Pamidronate—Hypotension—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Pamidronate—Convulsion—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Pamidronate—Hypertension—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Pamidronate—Chills—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Pamidronate—Myalgia—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Pamidronate—Arthralgia—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Pamidronate—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Pamidronate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000998	0.000998	CcSEcCtD
Pamidronate—Anxiety—Prednisone—psoriatic arthritis	0.000997	0.000997	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—psoriatic arthritis	0.000997	0.000997	CcSEcCtD
Pamidronate—Insomnia—Dexamethasone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Pamidronate—Insomnia—Betamethasone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Pamidronate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Pamidronate—Paraesthesia—Betamethasone—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Pamidronate—Discomfort—Prednisone—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Pamidronate—Erythema—Methotrexate—psoriatic arthritis	0.000982	0.000982	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—psoriatic arthritis	0.000982	0.000982	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000972	0.000972	CcSEcCtD
Pamidronate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Pamidronate—Dyspepsia—Betamethasone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—psoriatic arthritis	0.000961	0.000961	CcSEcCtD
Pamidronate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000959	0.000959	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000959	0.000959	CcSEcCtD
Pamidronate—Oedema—Prednisone—psoriatic arthritis	0.000959	0.000959	CcSEcCtD
Pamidronate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000957	0.000957	CcSEcCtD
Pamidronate—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000957	0.000957	CcSEcCtD
Pamidronate—Decreased appetite—Betamethasone—psoriatic arthritis	0.000957	0.000957	CcSEcCtD
Pamidronate—Infection—Prednisone—psoriatic arthritis	0.000952	0.000952	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Pamidronate—Back pain—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Pamidronate—Fatigue—Dexamethasone—psoriatic arthritis	0.000949	0.000949	CcSEcCtD
Pamidronate—Fatigue—Betamethasone—psoriatic arthritis	0.000949	0.000949	CcSEcCtD
Pamidronate—Shock—Prednisone—psoriatic arthritis	0.000943	0.000943	CcSEcCtD
Pamidronate—Pain—Dexamethasone—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Pamidronate—Pain—Betamethasone—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Pamidronate—Nervous system disorder—Prednisone—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—psoriatic arthritis	0.000936	0.000936	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000927	0.000927	CcSEcCtD
Pamidronate—Anorexia—Prednisone—psoriatic arthritis	0.000914	0.000914	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000911	0.000911	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Pamidronate—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Pamidronate—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Pamidronate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Pamidronate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Pamidronate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Pamidronate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Pamidronate—Malaise—Methotrexate—psoriatic arthritis	0.000885	0.000885	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—psoriatic arthritis	0.000879	0.000879	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000873	0.000873	CcSEcCtD
Pamidronate—Dizziness—Prednisolone—psoriatic arthritis	0.000872	0.000872	CcSEcCtD
Pamidronate—Asthenia—Triamcinolone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Pamidronate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Pamidronate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Pamidronate—Body temperature increased—Betamethasone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Pamidronate—Abdominal pain—Betamethasone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Pamidronate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000869	0.000869	CcSEcCtD
Pamidronate—Insomnia—Prednisone—psoriatic arthritis	0.000867	0.000867	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—psoriatic arthritis	0.000861	0.000861	CcSEcCtD
Pamidronate—Pruritus—Triamcinolone—psoriatic arthritis	0.000858	0.000858	CcSEcCtD
Pamidronate—Cough—Methotrexate—psoriatic arthritis	0.000857	0.000857	CcSEcCtD
Pamidronate—Pruritus—Methylprednisolone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—psoriatic arthritis	0.000851	0.000851	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—psoriatic arthritis	0.000844	0.000844	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—psoriatic arthritis	0.000833	0.000833	CcSEcCtD
Pamidronate—Rash—Prednisolone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Pamidronate—Dermatitis—Prednisolone—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Pamidronate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000828	0.000828	CcSEcCtD
Pamidronate—Fatigue—Prednisone—psoriatic arthritis	0.000827	0.000827	CcSEcCtD
Pamidronate—Headache—Prednisolone—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—psoriatic arthritis	0.000826	0.000826	CcSEcCtD
Pamidronate—Constipation—Prednisone—psoriatic arthritis	0.00082	0.00082	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
Pamidronate—Dizziness—Triamcinolone—psoriatic arthritis	0.000802	0.000802	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000801	0.000801	CcSEcCtD
Pamidronate—Dizziness—Methylprednisolone—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Pamidronate—Infection—Methotrexate—psoriatic arthritis	0.000796	0.000796	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Pamidronate—Asthenia—Dexamethasone—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Pamidronate—Asthenia—Betamethasone—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000786	0.000786	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Pamidronate—Nausea—Prednisolone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Pamidronate—Pruritus—Betamethasone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Pamidronate—Pruritus—Dexamethasone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000775	0.000775	CcSEcCtD
Pamidronate—Vomiting—Triamcinolone—psoriatic arthritis	0.000771	0.000771	CcSEcCtD
Pamidronate—Vomiting—Methylprednisolone—psoriatic arthritis	0.00077	0.00077	CcSEcCtD
Pamidronate—Rash—Triamcinolone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Pamidronate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000764	0.000764	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—psoriatic arthritis	0.000764	0.000764	CcSEcCtD
Pamidronate—Rash—Methylprednisolone—psoriatic arthritis	0.000763	0.000763	CcSEcCtD
Pamidronate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000763	0.000763	CcSEcCtD
Pamidronate—Headache—Triamcinolone—psoriatic arthritis	0.00076	0.00076	CcSEcCtD
Pamidronate—Headache—Methylprednisolone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Pamidronate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Pamidronate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—psoriatic arthritis	0.000749	0.000749	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00073	0.00073	CcSEcCtD
Pamidronate—Dizziness—Betamethasone—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Pamidronate—Dizziness—Dexamethasone—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Pamidronate—Nausea—Triamcinolone—psoriatic arthritis	0.000721	0.000721	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Pamidronate—Nausea—Methylprednisolone—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000714	0.000714	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—psoriatic arthritis	0.000712	0.000712	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000706	0.000706	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—psoriatic arthritis	0.000705	0.000705	CcSEcCtD
Pamidronate—Vomiting—Betamethasone—psoriatic arthritis	0.0007	0.0007	CcSEcCtD
Pamidronate—Vomiting—Dexamethasone—psoriatic arthritis	0.0007	0.0007	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—psoriatic arthritis	0.000696	0.000696	CcSEcCtD
Pamidronate—Rash—Betamethasone—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Pamidronate—Rash—Dexamethasone—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Pamidronate—Dermatitis—Betamethasone—psoriatic arthritis	0.000693	0.000693	CcSEcCtD
Pamidronate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000693	0.000693	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000692	0.000692	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—psoriatic arthritis	0.000691	0.000691	CcSEcCtD
Pamidronate—Headache—Dexamethasone—psoriatic arthritis	0.00069	0.00069	CcSEcCtD
Pamidronate—Headache—Betamethasone—psoriatic arthritis	0.00069	0.00069	CcSEcCtD
Pamidronate—Asthenia—Prednisone—psoriatic arthritis	0.000688	0.000688	CcSEcCtD
Pamidronate—Pain—Methotrexate—psoriatic arthritis	0.000685	0.000685	CcSEcCtD
Pamidronate—Pruritus—Prednisone—psoriatic arthritis	0.000678	0.000678	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00066	0.00066	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—psoriatic arthritis	0.000656	0.000656	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000655	0.000655	CcSEcCtD
Pamidronate—Nausea—Betamethasone—psoriatic arthritis	0.000654	0.000654	CcSEcCtD
Pamidronate—Nausea—Dexamethasone—psoriatic arthritis	0.000654	0.000654	CcSEcCtD
Pamidronate—Dizziness—Prednisone—psoriatic arthritis	0.000634	0.000634	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000633	0.000633	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000633	0.000633	CcSEcCtD
Pamidronate—Vomiting—Prednisone—psoriatic arthritis	0.00061	0.00061	CcSEcCtD
Pamidronate—Rash—Prednisone—psoriatic arthritis	0.000604	0.000604	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—psoriatic arthritis	0.000604	0.000604	CcSEcCtD
Pamidronate—Headache—Prednisone—psoriatic arthritis	0.000601	0.000601	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00059	0.00059	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—psoriatic arthritis	0.000575	0.000575	CcSEcCtD
Pamidronate—Nausea—Prednisone—psoriatic arthritis	0.000569	0.000569	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—psoriatic arthritis	0.000567	0.000567	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000548	0.000548	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—psoriatic arthritis	0.00053	0.00053	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—psoriatic arthritis	0.000509	0.000509	CcSEcCtD
Pamidronate—Rash—Methotrexate—psoriatic arthritis	0.000505	0.000505	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—psoriatic arthritis	0.000505	0.000505	CcSEcCtD
Pamidronate—Headache—Methotrexate—psoriatic arthritis	0.000502	0.000502	CcSEcCtD
Pamidronate—Nausea—Methotrexate—psoriatic arthritis	0.000476	0.000476	CcSEcCtD
